Mirae Asset Global ETFs Holdings’s Disc Medicine IRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
16,114
-585
-4% -$40.2K ﹤0.01% 1556
2026
Q1
$1.06M Buy
16,699
+2,988
+22% +$207K ﹤0.01% 1499
2025
Q4
$1.08M Buy
13,711
+1,065
+8% +$90K ﹤0.01% 1468
2025
Q3
$834K Sell
12,646
-2,395
-16% -$142K ﹤0.01% 1594
2025
Q2
$799K Sell
15,041
-97
-0.6% -$4.56K ﹤0.01% 1555
2025
Q1
$756K Buy
15,138
+2,807
+23% +$156K ﹤0.01% 1635
2024
Q4
$780K Buy
12,331
+69
+0.6% +$3.99K ﹤0.01% 1681
2024
Q3
$604K Buy
12,262
+6,478
+112% +$304K ﹤0.01% 1826
2024
Q2
$260K Buy
+5,784
New +$197K ﹤0.01% 2133

Other funds holding IRON

Mirae Asset Global ETFs Holdings's IRON Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Disc Medicine (IRON) stake by 3.5% in Q2 2026, selling an estimated $40.2K and leaving 16,114 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1556.

Mirae Asset Global ETFs Holdings first reported a position in IRON in Q2 2024 and has held it in 9 quarters since. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 16,114 shares of Disc Medicine worth $1.18M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 585 Disc Medicine shares in Q2 2026, an estimated $40.2K.
  • Disc Medicine made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1556 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Disc Medicine in Q2 2024 and has held it in 9 quarters since.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.